STOCK TITAN

Beta Bionics (BBNX) sees 6.9% stake reported by Divisadero Street group

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Beta Bionics, Inc. has a new significant shareholder group disclosed in a Schedule 13G filing. Divisadero Street Capital Management, LP and related entities, together with William Zolezzi, report beneficial ownership of 3,072,985 shares of common stock, representing 6.9% of the class.

Within this group, Divisadero Street Partners, L.P. and its general partner Divisadero Street Partners GP, LLC each report beneficial ownership of 2,612,985 shares, or 5.9% of the common stock. Voting and dispositive rights are reported only on a shared basis; all reporting persons list zero shares with sole voting or dispositive power.

The securities are directly owned by advisory clients of Divisadero Street Capital Management, LP, and, other than Divisadero Street Partners, L.P., no individual advisory client is stated to beneficially own more than 5% of the common stock. Each reporting person disclaims beneficial ownership beyond its pecuniary interest.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 3,072,985 shares Divisadero Street Capital Management, LP and William Zolezzi beneficial ownership of Beta Bionics common stock
Percent of class 6.9% Ownership percentage reported by Divisadero Street Capital Management, LP, William Zolezzi, and Divisadero Street Capital, LLC
Shares beneficially owned 2,612,985 shares Divisadero Street Partners, L.P. and Divisadero Street Partners GP, LLC beneficial ownership of Beta Bionics common stock
Percent of class 5.9% Ownership percentage reported by Divisadero Street Partners, L.P. and Divisadero Street Partners GP, LLC
Shared voting power 3,072,985 shares Shared voting power reported by Divisadero Street Capital Management, LP, William Zolezzi, and Divisadero Street Capital, LLC
Shared voting power 2,612,985 shares Shared voting power reported by Divisadero Street Partners, L.P. and Divisadero Street Partners GP, LLC
Sole voting power 0 shares Each reporting person’s sole power to vote Beta Bionics common stock
Par value per share $0.0001 Par value of Beta Bionics common stock reported in the Schedule 13G
beneficially owned financial
"Amount beneficially owned: Divisadero Street Capital Management, LP - 3,072,985"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 3,072,985.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 3,072,985.00"
pecuniary interest financial
"disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest"
Investment Company Act of 1940 regulatory
"shareholders of an investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
parent holding company financial
"Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake in Beta Bionics (BBNX) does Divisadero Street Capital Management report?

Divisadero Street Capital Management, LP reports beneficial ownership of 3,072,985 shares of Beta Bionics common stock, representing 6.9% of the outstanding class, with only shared voting and dispositive power over these shares.

How many Beta Bionics (BBNX) shares does Divisadero Street Partners, L.P. own?

Divisadero Street Partners, L.P. reports beneficial ownership of 2,612,985 shares of Beta Bionics common stock, equal to 5.9% of the class, with shared voting and shared dispositive power over all of these shares.

What is William Zolezzi’s reported ownership in Beta Bionics (BBNX)?

William Zolezzi is reported as beneficially owning 3,072,985 shares of Beta Bionics, or 6.9% of the common stock, with shared voting and dispositive power and no sole power over any shares.

Who directly owns the Beta Bionics (BBNX) shares reported on this Schedule 13G?

All reported Beta Bionics securities are directly owned by advisory clients of Divisadero Street Capital Management, LP. Except for Divisadero Street Partners, L.P., no individual advisory client is stated to beneficially own more than 5% of the common stock.

Do the Divisadero reporting persons admit full beneficial ownership of Beta Bionics (BBNX) shares?

No. Each reporting person disclaims beneficial ownership of the reported Beta Bionics securities except to the extent of their pecuniary interest, stating the filing is not an admission of beneficial ownership.





08659B102

(CUSIP Number)
07/17/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Divisadero Street Capital Management, LP
Signature:By: Divisadero Street Capital, LLC, its general partner, By: /s/ William Zolezzi
Name/Title:William Zolezzi, Manager
Date:07/24/2026
William Zolezzi
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi
Date:07/24/2026
Divisadero Street Partners, L.P.
Signature:By: Divisadero Street Partners GP, LLC, its general partner, By: /s/ William Zolezzi
Name/Title:William Zolezzi, Manager
Date:07/24/2026
Divisadero Street Partners GP, LLC
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi, Manager
Date:07/24/2026
Divisadero Street Capital, LLC
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi, Manager
Date:07/24/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification